PubMed:28777492 / 18-81
Annnotations
LitCoin-entities
{"project":"LitCoin-entities","denotations":[{"id":"13252","span":{"begin":19,"end":25},"obj":"DiseaseOrPhenotypicFeature"},{"id":"13253","span":{"begin":47,"end":56},"obj":"ChemicalEntity"}],"attributes":[{"id":"A3","pred":"db_id","subj":"13252","obj":"MESH:D009369"},{"id":"A4","pred":"db_id","subj":"13253","obj":"MESH:D000077157"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"TAT3 activation in tumour microenvironment and sorafenib resist"}
LitCoin-GeneOrGeneProduct-v0
{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T4","span":{"begin":5,"end":15},"obj":"GeneOrGeneProduct"}],"text":"TAT3 activation in tumour microenvironment and sorafenib resist"}
LitCoin-Disease-MeSH
{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T1","span":{"begin":19,"end":25},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"originalLabel","subj":"T1","obj":"DISEASE"}],"text":"TAT3 activation in tumour microenvironment and sorafenib resist"}
LitCoin-MeSH-Disease-2
{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T1","span":{"begin":19,"end":25},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"DISEASE"}],"text":"TAT3 activation in tumour microenvironment and sorafenib resist"}
LitCoin-MONDO_bioort2019
{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T1","span":{"begin":19,"end":25},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"#label","subj":"T1","obj":"DISEASE"}],"text":"TAT3 activation in tumour microenvironment and sorafenib resist"}
LitCoin-Chemical-MeSH-CHEBI
{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T1","span":{"begin":47,"end":56},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"D000077157"},{"id":"A2","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_50924"}],"text":"TAT3 activation in tumour microenvironment and sorafenib resist"}
LitCoin-training-merged
{"project":"LitCoin-training-merged","denotations":[{"id":"T1","span":{"begin":47,"end":56},"obj":"ChemicalEntity"},{"id":"T24854","span":{"begin":19,"end":25},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_50924"},{"id":"A1","pred":"ID:","subj":"T1","obj":"D000077157"},{"id":"A35740","pred":"#label","subj":"T24854","obj":"DISEASE"}],"text":"TAT3 activation in tumour microenvironment and sorafenib resist"}